Buy or sell Lycia Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Lycia Therapeutics Stock

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

About Lycia Therapeutics Stock

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.

Funding History

June 2020$50.0M
September 2021$70.0M

Management

Board Member

Timothy Anderson

Board Member

Clare Ozawa

Vice President, Head of Biology

Sarah McWhirter

Chief Scientific Officer

Steve Staben

Founder

Carolyn Bertozzi

Chief Executive Officer

Aetna Wun Trombley

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo